1. Therapeutic efficacy of the paradox-breaking panRAF and SRC drug CCT3833/BAL3833 in KRAS-driven cancer models. (July 2016) Authors: Saturno, G.; Lopes, F.; Girotti, M.R.; Niculescu-Duvaz, I.; Niculescu-Duvaz, D.; Zambon, A.; Davies, L.; Johnson, L.; Preece, N.; Viros, A.; Pedersen, M.; McLeary, R.; Knight, R.; Lee, R.; Holovanchuk, D.; Fusi, A.; Lorigan, P.; Dhomen, N.; Marais, R.; Springer, C. Journal: European journal of cancer Issue: Volume 61(2016)Supplement 1 Page Start: S199 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Lysyl oxidase regulates EGFR signalling through the extracellular matrix. (July 2016) Authors: Tang, H.; Leung, L.; Saturno, G.; Viros, A.; Di Leva, G.; Morrison, E.; Smith, D.; Johnson, L.; Dhomen, N.; Springer, C.; Marais, R. Journal: European journal of cancer Issue: Volume 61(2016)Supplement 1 Page Start: S57 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Sustainability assessment of electricity cogeneration from sugarcane bagasse in Jamaica. (1st November 2018) Authors: Contreras-Lisperguer, R.; Batuecas, E.; Mayo, C.; Díaz, R.; Pérez, F.J.; Springer, C. Journal: Journal of cleaner production Issue: Volume 200(2018) Page Start: 390 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗